Five-year results of atropine 0.01% efficacy in the myopia control in a European population.

Manuel Moriche-CarreteroRemedios Revilla-AmoresAna Gutiérrez-BlancoFrancisco Javier Moreno-MorilloClara Martinez-PerezMiguel Angel M A Sanchez-Tena Cristina C Alvarez-Peregrina

Published in: The British journal of ophthalmology (2023)

Atropine 0.01% is effective in slowing myopia progression in a European population. There were no side effects after 5 years of 0.01% atropine.

Keyphrases